Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

January 10, 2024

Study Completion Date

July 30, 2024

Conditions

Fibromyalgia

Interventions

DRUG

Psilocybin

Up to 25mg of Psilocybin on 2 occasions.

BEHAVIORAL

Therapeutic support

Psychological and physical therapeutic support

Trial Locations (1)

Imperial College London, London

All Listed Sponsors

lead

Imperial College London

OTHER